This might be due to mutations in MAP3K14/NIK or MAP3K1/MEKK1 of TE617.T cells, which result in an alternative splice variant or a threonine deletion at position 949, respectively (The Cancer Cell Line Encyclopedia [30]). The gene discussed is MAP3K14; the disease is cancer.